11.4  0.04 (0.35%)		03-13 16:00
Open: 11.36 High: 11.66 Volume: 73,674		Pre. Close: 11.36 Low: 11.15 Market Cap: 305(M)

Short term
Mid term
Targets	6-month :	15.71	1-year :	17.74
Resists	First :	13.45	Second :	15.18
Pivot price	12.65
Supports	First :	10.64	Second :	8.86
MAs	MA(5) :	11.63	MA(20) :	12.45
	MA(100) :	12.89	MA(250) :	0
MACD	MACD :	-0.3	Signal :	-0.1
%K %D	K(14,3) :	8.1	D(3) :	12.7
RSI	RSI(14): 40
52-week	High :	17.19	Low :	10.64

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ CARL ] has closed above bottom band by 18.0%. Bollinger Bands are 21.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	11.69 - 11.76	11.76 - 11.83
Low:	10.96 - 11.06	11.06 - 11.15
Close:	11.25 - 11.4	11.4 - 11.54

Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies. Its product includes aprevo, a medical platform that makes surgical plans and devices tailored to the precise medical situation of every individual patient. It provides New Technology Add-On Payment (NTAP) reimbursement. The company was incorporated in 2018 and is based in Carlsbad, California.

Mon, 02 Mar 2026
CARL: Personalized spine surgery platform drives rapid growth, clinical success, and strong reimbursement - TradingView

Fri, 27 Feb 2026
Carlsmed, Inc. (NASDAQ:CARL) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

Wed, 25 Feb 2026
Carlsmed Inc (NASDAQ:CARL) Reports Q4 Revenue Beat and Narrower-Than-Expected Loss - ChartMill

Thu, 22 Jan 2026
Bullish Carlsmed Insiders Loaded Up On US$8.10m Of Stock - Yahoo Finance

Fri, 26 Dec 2025
Carlsmed Debuts AI-based Custom Implants for Cervical Spine Surgery - San Diego Business Journal

Sat, 29 Nov 2025
Carlsmed: Back To Where We Started - Seeking Alpha

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Shares Out	27 (M)
Shares Float	10 (M)
Held by Insiders	43.5 (%)
Held by Institutions	38.6 (%)
Shares Short	624 (K)
Shares Short P.Month	690 (K)

EPS	-2.12
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	3.72
Profit Margin	-58.7 %
Operating Margin	-61.5 %
Return on Assets (ttm)	-21 %
Return on Equity (ttm)	-47.7 %
Qtrly Rev. Growth	61.2 %
Gross Profit (p.s.)	1.42
Sales Per Share	1.88
EBITDA (p.s.)	-1.14
Qtrly Earnings Growth	0 %
Operating Cash Flow	-29 (M)
Levered Free Cash Flow	-22 (M)

PE Ratio	-5.38
PEG Ratio	0
Price to Book value	3.06
Price to Sales	6.03
Price to Cash Flow	-10.52

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.